Jinjun Liu

Dr. Jinjun Liu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
JWJun Wang
Jun Wang
YWYijun Wang
Yijun Wang
SDShoupeng Duan
Shoupeng Duan
LXLi Xu
Li Xu
YXYanan Xu
Yanan Xu
JLJinjun Liu
Jinjun Liu
Background: Limited data from the literature are available to assess the efficacy of coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure with preserved ejection fraction. Therefore, our objective was to use machine learning techniques integrating clinical features, biomarker data, and echocardiography data to enhance comprehension and risk stratification in patients diagnosed with ischemic cardiomyopathy and heart failure with preserved ejection fraction who have undergone coronary artery bypass grafting surgery. Methods and Results: For this study, 294 patients with ischemic cardiomyopathy and heart failure with preserved ejection fraction who underwent coronary artery bypass grafting surgery were assigned to the development cohort (n=176) and the independent validation cohort (n=118). A total of 52 clinical variables were extracted for each patient. The principal clinical end point was the incidence of major adverse cardiovascular events, encompassing cardiac mortality, acute myocardial infarction, acute heart failure, and graft failure. From least absolute shrinkage and selection operator regression, 4 predictors were selected for the final prediction nomogram: diabetes, hypertension, the systemic immune‐inflammation index, and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide). The prediction nomogram achieved satisfactory prediction performance in both the development cohort (C index, 0.768 [95% CI, 0.701–0.835]) and independent validation cohort (C index, 0.633 [95% CI, 0.521–0.745]). Adequate calibration was noted for the likelihood of major adverse cardiovascular events in both the development and independent validation cohorts. Decision curve analysis confirmed the clinical usefulness of the established prediction nomogram. Conclusions: A clinically feasible prognostic model, based on preoperative multimodal data, was developed for risk stratification of patients with ischemic heart and heart failure with preserved ejection fraction who receive coronary artery bypass grafting surgery. Registration: https://www.chictr.org.cn ; Unique identifier: ChiCTR2300074439.

1 May 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JWJun Wang
Jun Wang
JZJiajun Zhu
Jiajun Zhu
HLHui Li
Hui Li
SWShili Wu
Shili Wu
SLSiyang Li
Siyang Li
JLJinjun Liu
Jinjun Liu
Background: Currently, there is a paucity of literature addressing personalized risk stratification using multimodal data in patients with symptomatic aortic stenosis and heart failure with preserved ejection fraction (HFpEF) following transcatheter aortic valve replacement (TAVR). Objective: This study aimed to enhance the performance of risk assessment models in this patient population by developing a predictive model for adverse outcomes using various machine learning (ML) techniques. Methods: This multicenter cohort study included 326 patients diagnosed with severe AS and HFpEF who underwent TAVR between January 2017 and December 2023. Patients were allocated to training (n=195) and independent validation (n=131) sets based on hospital affiliation. A dual-phase feature selection process, combining least absolute shrinkage and selection operator logistic regression and the Boruta algorithm, was used to identify relevant variables from the multimodal dataset. A total of 5 ML model-decision trees, K-nearest neighbors, random forest, support vector machine, and extreme gradient boosting were used to construct a visualization and explainable predictive framework to elucidate model decision-making processes. Results: The primary features identified included age, N-terminal pro-brain natriuretic peptide, fasting blood glucose, triglyceride/high-density lipoprotein cholesterol ratio, triglyceride glucose index, triglyceride glucose-BMI index, atherogenic index of plasma index, and Apolipoprotein B. Among the 5 models, the support vector machine demonstrated the best predictive performance for major adverse cardiovascular and cerebrovascular events in patients with severe AS and HFpEF following TAVR, achieving an area under the curve of 0.756 (95% CI 0.631-0.881) in the independent validation set. The model exhibited good calibration and robust predictive power in both training and validation sets and demonstrated the highest net benefit in decision curve analysis compared to other models. To extract significant variables influencing the algorithm and ensure model appropriateness, we interpreted cohort and personalized model predictions using Shapley Additive Explanations values. Conclusions: Our ML-based multimodal model, incorporating 8 readily accessible predictors, demonstrated robust predictive capability for 12 months of major adverse cardiovascular and cerebrovascular events risk. This model can be used to identify high-risk individuals with AS and HFpEF following TAVR, potentially aiding in risk stratification and personalized treatment strategies.

2 April 2025 in Journal of Medical Systems
Verified
Journal Article
Closed access
PDF file
YWYijun Wang
Yijun Wang
TZTongjian Zhu
Tongjian Zhu
TZTong Zhou
Tong Zhou
BWBing Wu
Bing Wu
WTWuping Tan
Wuping Tan
JWJun Wang
Jun Wang

1 October 2025 in Journal of Atherosclerosis and Thrombosis
Verified
Journal Article
Open access
HRHuaiyu Ruan
Huaiyu Ruan
SDShoupeng Duan
Shoupeng Duan
LHLiying He
Liying He
YWYijun Wang
Yijun Wang
ZYZhuoya Yao
Zhuoya Yao
JWJun Wang
Jun Wang
The triglyceride-glucose (TyG) index, a biomarker commonly used to evaluate metabolic health status, can predict unfavorable outcomes. Thus, we aimed to explore evidence regarding the prognostic value of the TyG index in patients with ischemic cardiomyopathy and heart failure with preserved ejection fraction (HFpEF). We enrolled 277 consecutive participants with new-onset ischemic cardiomyopathy and HFpEF who underwent coronary artery bypass grafting (CABG). The primary study endpoint was major adverse cardiovascular events (MACEs), defined as cardiac death, acute myocardial infarction, graft failure, and stroke. During a median follow-up of 43.34 months, 70 patients (25.1%) experienced MACEs. A multivariable Cox regression analysis identified the TyG index as an independent risk factor for MACEs, with a higher baseline TyG index associated with greater risk after adjusting for confounding factors. A restricted cubic spline showed that the TyG index had a linear relationship across the range. The optimal cut-off value of 9.167 for the TyG index demonstrated a sensitivity of 70% and specificity of 84.1%, with an AUC of 0.820 (p<0.001, 95% CI: 0.762-0.878), thus effectively stratifying participants into lower TyG index (TyG <9.167, n = 182) and higher TyG index groups (TyG ≥ 9.167, n = 95), while subgroup analyses confirmed a robust association with MACEs across various populations. Furthermore, the time-dependent area under the curve, calibration curve, and decision curve analyses demonstrated that incorporating the TyG index into the traditional cardiovascular risk factor model significantly enhanced the prediction of MACE risk. Additionally, significant net reclassification improvement (0.335, 95% confidence interval [CI]: 0.136-0.518, p<0.05) and integrated discrimination improvement (0.178, 95%CI: 0.089-0.270, p<0.001) were also observed. The TyG index is a reliable prognostic indicator for MACEs after CABG in patients with ischemic cardiomyopathy and HFpEF and it serves as a valuable complement to traditional cardiovascular risk factors by providing metabolic-related insights.

1 January 2026 in Hypertension
Verified
Journal Article
Closed access
YWYijun Wang
Yijun Wang
WTWuping Tan
Wuping Tan
SCSiyi Cheng
Siyi Cheng
CPChen Peng
Chen Peng
JPJin Peng
Jin Peng
JWJun Wang
Jun Wang
BACKGROUND: The effectiveness of Large Language Model agent frameworks for hypertension screening and personalized health management has not been fully studied. This study aimed to develop and evaluate a Large Language Model–based Agent, called the Cascade Framework, and assess its effectiveness in hypertension education and clinical decision support. METHODS: The Cascade Framework was developed utilizing the Dify platform, and its performance was tested via a robust 2-phase evaluation protocol from August 2024 to June 2025. The first phase involved systematic performance benchmarking of 6 configurations: 3 foundational Large Language Models (Chat Generative Pretrained Transformer [ChatGPT]-4o, ChatGPT-4oMini, and DeepSeek-V3) and their respective Cascade-enhanced versions. The second phase included an external validation in a cohort of patients with suspected hypertension. RESULTS: Cascade integration yielded significant performance improvements across all models. For ChatGPT-4o, educational outcomes improved (Accuracy: 3.87→4.10, P =0.02; Comprehensiveness: 4.07→4.32, P =0.16; Credibility: 3.79→4.03, P <0.001; Understandability: 3.90→3.96, P =0.005; Emotional Support: 3.87→4.01, P <0.001). Blood pressure classification accuracy rose from 62.5% to 87.0% ( P <0.001) and risk factor stratification from 60.4% to 98.6% ( P <0.001). Clinical decision-making improved, with accuracy of 72.0% to 92.5%. A similar trend of performance improvement was observed in the external validation cohort, where the 4o-Cascade model achieved increases in blood pressure classification accuracy (58.9%→95.3%), risk stratification accuracy (71.0%→90.7%), and clinical decision appropriateness (66.4%→92.5%), all with P <0.001 and surpassing the performance of the 3 physicians. CONCLUSIONS: Cascade Framework can improve the management of hypertension. Its extensible architecture allows integration with existing clinical workflows while providing transparent reasoning pathways.

1 December 2024 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
BZBowen Zhou
Bowen Zhou
WTWuping Tan
Wuping Tan
SDShoupeng Duan
Shoupeng Duan
YWYijun Wang
Yijun Wang
FBFenlan Bian
Fenlan Bian
JLJinjun Liu
Jinjun Liu
Objective: Angina, a prevalent manifestation of coronary artery disease, is primarily associated with inflammation, an established contributor to the pathogenesis of atherosclerosis and acute coronary syndromes (ACS). Various inflammatory markers are employed in clinical practice to predict patient prognosis and optimize clinical decision-making in the management of ACS. This study investigated the prognostic significance of integrating commonly used, easily repeatable inflammatory biomarkers within a multimodal preoperative prediction model in patients presenting with unstable Angina Pectoris (UAP) and intermediate coronary lesions. Methods: This retrospective analysis included patients diagnosed with UAP and intermediate coronary lesions (50%– 70% stenosis) who underwent coronary angiography at our hospital between January 2019 and June 2021. The assessed outcome was the occurrence of major adverse cardiac and cerebrovascular events (MACCEs). The Boruta algorithm was applied to identify potential risk factors and develop a prognostic multimodal model. Results: A total of 773 patients were enrolled and divided into a training cohort (n=463) and validation cohort (n=310). A nomogram was constructed to predict the probability of MACCE-free survival based on five clinical features: diabetes mellitus, current smoking, history of myocardial infarction, neutrophil-to-lymphocyte ratio, and fasting blood glucose. In the training cohort, the area under the curve values for the nomogram at 24, 32, and 40 months were 0.669, 0.707, and 0.718, respectively, while those in the validation cohort were 0.613, 0.612 and 0.630, respectively. The model demonstrated good calibration in both cohorts with predicted outcomes aligning well with actual results at all time points up to 40 months. Furthermore, decision curve analysis showed significant clinical utility of the model across the specified time intervals. Conclusion: The developed preoperative prognostic model visually illustrates the association among inflammation, blood glucose level, established risk factors, and long-term MACCEs in UAP patients with intermediate coronary lesions.